Bonani et al. found that the serum concentration of sclerostin rapid lowered and paralleled the improvements of renal function after receiving renal transplantation and proposed that decreased renal clearance might be responsible for the accumulation of sclerostin in late stage of CKD [30]. The gene discussed is SOST; the disease is chronic kidney disease.